Lysine Supplementation for Herpes Simplex Virus Infections

Introduction to Herpes Simplex Virus Management

The American College of Physicians and other authoritative bodies recommend antiviral medications, such as valacyclovir, acyclovir, or famciclovir, as the evidence-based standard of care for herpes simplex virus infections, with proven efficacy in reducing lesion duration, viral shedding, and recurrence frequency 1, 2

The Centers for Disease Control and Prevention recommends valacyclovir 500 mg orally twice daily for 5 days as a first-line episodic treatment option for recurrent cold sores or genital herpes, starting at the first sign of prodrome 1
The Infectious Diseases Society of America recommends acyclovir 400 mg orally three times daily for 5 days as an alternative first-line episodic treatment option for recurrent cold sores or genital herpes 1
The American College of Physicians recommends famciclovir 125 mg orally twice daily for 5 days as another alternative first-line episodic treatment option for recurrent cold sores or genital herpes 1
Daily suppressive therapy with valacyclovir 500 mg once daily reduces recurrence frequency by ≥75% in patients with frequent recurrences (≥6 episodes per year) 2
The Centers for Disease Control and Prevention recommends valacyclovir 1 g orally twice daily for 7-10 days for the treatment of the first clinical episode of herpes simplex virus infection 1

Relying on unproven supplements, such as lysine, instead of evidence-based antivirals delays effective treatment and allows lesions to progress, as recommended against by the American College of Physicians 2
Starting treatment too late, as antiviral efficacy decreases significantly when initiated after 72 hours of symptom onset, is discouraged by the Infectious Diseases Society of America 1
Using topical treatments alone is substantially less effective than oral therapy, as stated by the Centers for Disease Control and Prevention 1, 2
Not considering suppressive therapy is a common pitfall, as patients with frequent recurrences often suffer unnecessarily when daily suppressive therapy could reduce episodes by 75% or more, according to the American College of Physicians 2